4DMedical Limited
FDMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $2,958 | $2,895 | $2,962 | $793 |
| % Growth | 2.2% | -2.2% | 273.7% | – |
| Cost of Goods Sold | $276 | $188 | $18,528 | $13,605 |
| Gross Profit | $2,682 | $2,707 | -$15,567 | -$12,813 |
| % Margin | 90.7% | 93.5% | -525.6% | -1,616.8% |
| R&D Expenses | $2,160 | $347 | $2,832 | $2,066 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16,889 | $15,213 | $6,268 | $8,678 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19,049 | $15,560 | $9,100 | $10,744 |
| Operating Income | -$16,367 | -$12,853 | -$24,666 | -$23,557 |
| % Margin | -553.3% | -443.9% | -832.8% | -2,972.5% |
| Other Income/Exp. Net | $5,371 | -$6,307 | $2,665 | $5,163 |
| Pre-Tax Income | -$10,997 | -$19,160 | -$22,001 | -$18,394 |
| Tax Expense | $94 | $7 | -$1,629 | -$2,788 |
| Net Income | -$10,902 | -$19,168 | -$20,372 | -$15,606 |
| % Margin | -368.5% | -662% | -687.8% | -1,969.3% |
| EPS | -0.047 | -0.031 | -0.068 | -0.042 |
| % Growth | -52.6% | 54.4% | -61.9% | – |
| EPS Diluted | -0.17 | -0.031 | -0.068 | -0.042 |
| Weighted Avg Shares Out | 62,395 | 618,311 | 299,591 | 371,582 |
| Weighted Avg Shares Out Dil | 230,253 | 618,311 | 299,591 | 371,582 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $104 | $205 | $1,032 |
| Interest Expense | $24 | $0 | $137 | $127 |
| Depreciation & Amortization | $401 | $1,051 | $158 | $3,906 |
| EBITDA | -$23,596 | -$22,451 | -$22,190 | -$9,667 |
| % Margin | -797.7% | -775.4% | -749.2% | -1,219.8% |